Laboratory Testing

Evidence-Based Reports

Antiplatelet Treatment, Testing of CYP2C19 Variants and Platelet Reactivity (September 2013)
Comparative Effectiveness Review

Cancer Treatment, Selected Pharmacogenetic Tests (June 2010)
Technology Assessment Program

Cervical Cancer Testing, Fluorescence in Situ Hybridization (February 2013)
Technology Assessment Program

Colon Cancer, Gene Expression Profiling (December 2012)
Technical Brief

Colorectal Cancer Screening, Fecal DNA (February 2012)
Comparative Effectiveness Review

Genetic Tests, Noncancer Conditions (March 2010)
Technology Assessment Program

Heart Failure, Use of Natriuretic Peptide Measurement (November 2013)
Comparative Effectiveness Review

Molecular Pathology Testing or Genetic Testing to Determine Cancer Origin (February 2013)
Technology Assessment Program

Molecular Tests, Laboratory-Developed ( October 2010)
Technology Assessment Program

Pharmacogenetic Tests, Noncancer and Cancer Conditions (November 2008)
Technology Assessment Program

Plasma Cell Dyscrasias, Serum Free Light Chain Analysis (August 2012)
Comparative Effectiveness Review

Procalcitonin-Guided Antibiotic Therapy (October 2012)
Comparative Effectiveness Review

Prostate Cancer, PCA3 Testing (April 2013)
Comparative Effectiveness Review

Thiopurine Methyltransferase Activity (December 2010)
Evidence Report

Topographic Genotyping With Pathfinder TG® (March 2010)
Technology Assessment Program

Current as of June 2014
Internet Citation: Laboratory Testing: Evidence-Based Reports. June 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/evidence-based-reports/clinical/lab/index.html